Search

Parabolic Drugs

Sector: Healthcare | Industry: Drugs & Pharma
R 1.70 0.00  | 0.00% -79.27% - 10.52
NSE Price: Feb 18, 09:07 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Feb 18, 09:07 1.70 0.00 0.00% 0.00 1.70 0 0.00 - 0.00
BSE Feb 14, 2019 1.60 -0.01 -0.62% 1.53 1.61 3,600 1.53 - 1.60
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 10,749 P/B: -0.01 NSE Code: PARABDRUGS
52-Week Range: R 0.00 - 9.35 Dividend Yield: 0.00% BSE Code: 533211
TTM EPS: R -7.47 Book Value: R -146.46 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 34
Price Graph
  • Merck (NSE)
  • NIFTY 50


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 34 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Parabolic Drugs -34.62 -29.17 -37.04 -78.34 -37.88 -22.01 -
NIFTY Smallcap 100 -11.19 -11.20 -8.65 -32.17 8.11 12.68 13.77
NIFTY Pharma -2.54 -4.26 -6.24 -6.13 -8.25 2.27 14.97
Company's return has been calculated on basis of NSE's price.
As on Feb 15, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -2.33 -31.95 -37.49
Net Profit 46.76 22.73 9.88
EPS 46.76 22.73 9.87
Book Value -5.32 -190.75 -254.04
Average
Operating Margin -34.04 -195.79 -133.90
Net Margin -74.43 -279.06 -205.97
Return on Networth 0.00 0.00 -46.76
Return on Investment -31.96 -54.11 -39.50
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -94.77 -98.41 -98.40
Operating Profit 61.98 55.95 35.90
Net Profit 50.59 54.20 50.32
EPS 50.59 54.20 50.31
TTM
Revenue -31.98 -56.28 -52.75
Operating Profit 14.40 23.97 -26.36
Net Profit 15.36 -400.59 18.31
EPS 15.36 -400.58 18.31
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Parabolic Drugs 10.52 34.31 -46.23 -131.60 0.00 -0.01 -
Merck 5,184.48 1,051.73 150.62 11.53 13.44 6.37 41.84
Wockhardt 4,344.43 4,197.51 -355.67 -8.38 -21.81 1.60 -
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 14, 2016 BTS India Pvt Equity Fund Ltd  Sell Market 687,081 5.40 37.10
Jan 06, 2016 BTS India Pvt Equity Fund Ltd  Sell Market 1,391,000 10.20 141.88
Jul 04, 2014 Parabolic Infrastructure Pvt. Ltd.  Buy Market 26,424 8.65 2.29
Jun 25, 2014 Parabolic Infrastructure Pvt. Ltd.  Buy Market 44,653 7.50 3.35
Jun 25, 2014 Parabolic Infrastructure Pvt. Ltd.  Sell Market 7,740 7.50 0.58
Fund Houses invested in the stock
Fund Mar-13 Dec-12 Sep-12 Jun-12 Mar-12
UTI Mutual Fund 0.481 0.899 1.900 2.457 2.301
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Parabolic Drugs Ltd.

Address: S.c.o. 186-187, 2nd Floor, Sector 8c, Chandigarh, Punjab - 160017 | Phone: +91-172-3914646/3914647/38 | Fax: +91-172-3914645

Website: www.parabolicdrugs.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: Narang Tower 44, Community Centre,Naraina Industrial Area Phase - 1,New Delhi - 110 028, Narang Tower 44, Community Centre, Naraina Industrial Area, Phase - 1

Email: [email protected]

comments powered by Disqus
Essential checks
Altman Z-Score
-4.41
Piotroski F-Score
6
Modified C-Score
1
5-Years Price to Earnings
Not applicable
5-Years Price to Book
-0.01
Earnings Yield
EBIT / Enterprise value
-4.05%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R1,797.00 +1.09%
Caplin Point Laboratories R328.20 +0.91%
Dishman Carbogen Amcis R192.70 +0.92%
FDC R151.25 -0.40%
Laurus Labs R326.40 -0.31%
Merck R3,140.00 +0.58%
Shilpa Medicare R349.00 +0.10%
Strides Pharma Science R405.50 +0.83%
Sun Pharma Adv. Research R162.85 -0.37%
Wockhardt R395.50 +0.71%
As on Feb 18, 09:19